Tuesday, June 23, 2009

Forbes: Vescell Stem Cell Therapy Saves Heart Failure Patient

New Stem Cell Research Helping Heart Patients Now

Nashville, Tennessee 5/27/2009 12:00 PM GMT (TransWorldNews)

Vescell stem cell therapy, a treatment in which the patient’s own Adult Stem Cells are used to heal their heart disease was recently featured in a Forbes article.

The Forbes article focuses on Anderson Jordan, age 72, who had been suffering from congestive heart failure and severe coronary artery disease. Jordan, who at the time, was fading fast, took a leap of faith, even though his doctor resisted the idea of traveling from Nashville, Tennessee to Thailand for stem cell treatment.

As a result of having his own Adult Stem Cells implanted, Jordan’sejection fraction increased from 19% to 35%, which impressed his internist. Dr. William E. Baucom, Jordan's internist states in Forbes, "There is no way to know the exact reason, but [Jordan] has improved and he does look good today."

What is Vescell?A key aspect of VesCell therapy is the advanced cell isolation and expansion technique that allows for the stem cells to be harvested from blood collected in a procedure similar to a common blood donation. VesCell uses a patient’s own adult stem cells to treat Heart Disease and Peripheral Artery Disease (PAD) and is a viable therapeutic possibility for heart or PAD patients without any other treatment option.

Jordan is the latest heart patient treated with Vescell ™ stem cell treatment featured in a major publication. Other heart patients treated with Vescell ™ have been featured in Reuters, Business Weekly, twice in Time Magazine, World Economic Forum and seen on ABC and National Geographic.

Vescell ™ stem cell therapy is published in peer-reviewed journals such as The British Journal of Hematology, The European Journal of Heart Failure, BioProcessing Journal, Asian Cardiovascular Thoracic Annals, and the American Heart Association’s Circulation Research.

No comments:

Post a Comment